SynopsisGlobal Intravenous Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have le.....
SynopsisThe high-pressure balloon dilatation catheter is suitable for percutaneous transluminal angioplasty (PTA), which is the main surgical method for the treatment of peripheral vascular system diseases. It has the characteristics of pushability, tracking, and shor.....
SynopsisBiliary drainage sets, including biliary drainage catheters and biliary drainage bags, are used for biliary drainage. The global Biliary Drainage Sets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a .....
SynopsisHuman induced pluripotent stem cells (iPSCs) offer a more physiologically relevant way of studying neuronal activity in vitro, compared to immortalized cell lines and primary mouse neurons. However, differentiating stem cells into the desired cell type is a ti.....
The global Coil Assisted Flow Diverters market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Coil Assisted Flow Diverters is estimated to increas.....
SynopsisDeath Receptor 5 (DR5) Antibody is an antibody specific for DR5 protein. The global Death Receptor 5 (DR5) Antibody market was valued at US$ 394.6 million in 2023 and is anticipated to reach US$ 894.4 million by 2030, witnessing a CAGR of 12.4% during th.....
SynopsisThe global Birthmarks Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a .....
SynopsisThe primary role of a PPMC is to be a strategic partner for physicians. PPMCs can provide physicians with very focused and effective resources in terms of management expertise, capital, information systems and best practices both on the business and clinical s.....
SynopsisCetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. The global Cetuximab market was valued at US$ 51 million in 2023 and.....
SynopsisAvonex is a medicine used to treat: patients with relapsing multiple sclerosis (MS). The global Avonex market was valued at US$ 1324 million in 2023 and is anticipated to reach US$ 1062.9 million by 2030, witnessing a CAGR of -3.1% during the forecast pe.....
